ID: ALA5280241

Max Phase: Preclinical

Molecular Formula: C21H17ClN4O2

Molecular Weight: 392.85

Representations

Canonical SMILES:  O=C(Nc1cnccc1-c1ccccc1Cl)c1ccnc(NC(=O)C2CC2)c1

Standard InChI:  InChI=1S/C21H17ClN4O2/c22-17-4-2-1-3-15(17)16-8-9-23-12-18(16)25-21(28)14-7-10-24-19(11-14)26-20(27)13-5-6-13/h1-4,7-13H,5-6H2,(H,25,28)(H,24,26,27)

Standard InChI Key:  FIUNUJMCHFAOKT-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 392.85

Molecular Weight (Monoisotopic): 392.1040

AlogP: 4.40

#Rotatable Bonds: 5

Polar Surface Area: 83.98

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 11.95

CX Basic pKa: 4.27

CX LogP: 3.49

CX LogD: 3.49

Aromatic Rings: 3

Heavy Atoms: 28

QED Weighted: 0.67

Np Likeness Score: -1.58

References

1. Luo G, Chen L, Burton CR, Xiao H, Sivaprakasam P, Krause CM, Cao Y, Liu N, Lippy J, Clarke WJ, Snow K, Raybon J, Arora V, Pokross M, Kish K, Lewis HA, Langley DR, Macor JE, Dubowchik GM..  (2016)  Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors.,  59  (3): [PMID:26751161] [10.1021/acs.jmedchem.5b01550]

Source

Source(1):

• Scientific Literature